Kiyoto Nishi

发表

Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.

Takeshi Kimura, T. Kita, T. Hiwasa, 2016, International journal of cardiology.

Title Critical roles of nardilysin in the maintenance of bodytemperature homoeostasis

Takeshi Kimura, T. Kita, S. Matsumura, 2018 .

Critical roles of nardilysin in the maintenance of body temperature homoeostasis

Takeshi Kimura, T. Kita, S. Matsumura, 2014, Nature Communications.

Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.

H. Seno, Takeshi Kimura, T. Chiba, 2018, JCI insight.

Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.

R. Taniguchi, Yukihito Sato, H. Fujiwara, 2012, Journal of cardiology.

Serial measurements of high sensitive cardiac troponin I in patients with acutely decompensated heart failure treated with carperitide or nitrates.

R. Taniguchi, Yukihito Sato, H. Fujiwara, 2010, Journal of cardiology.

Serum Nardilysin, a Surrogate Marker for Epithelial–Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection

K. Iwaisako, E. Hatano, Takeshi Kimura, 2018, Clinical Cancer Research.

Glycaemia and body weight are regulated by sodium-glucose cotransporter 1 (SGLT1) expression via O-GlcNAcylation in the intestine

K. Morino, H. Maegawa, E. Nishi, 2022, Molecular metabolism.

Genome-wide profiling of nardilysin target genes reveals its role in epigenetic regulation and cell cycle progression

Takeshi Kimura, T. Kita, M. Ohno, 2017, Scientific Reports.

Increasing Fatty Acid Oxidation Prevents High-Fat Diet–Induced Cardiomyopathy Through Regulating Parkin-Mediated Mitophagy

Yun-Wei A Hsu, Weiqi Wang, R. Tian, 2020, Circulation.

The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST.

R. Taniguchi, Yukihito Sato, K. Nagao, 2009, Journal of cardiology.

In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events.

R. Taniguchi, E. Yamamoto, Yukihito Sato, 2009, Journal of Cardiology.

Improvement of insulin signalling rescues inflammatory cardiac dysfunction

Takeshi Kimura, N. Ashida, Masayuki Harada, 2019, Scientific Reports.

Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes.

R. Taniguchi, Yukihito Sato, H. Fujiwara, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Nardilysin in adipocytes regulates UCP1 expression and body temperature homeostasis

M. Ohno, E. Nishi, K. Nishi, 2022, Scientific Reports.

Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice

H. Seno, T. Chiba, S. Uemoto, 2018, Gut.

Nardilysin controls cardiac sympathetic innervation patterning through regulation of p75 neurotrophin receptor

Takeshi Kimura, E. Nishi, S. Niizuma, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Nardilysin Is Required for Maintaining Pancreatic β-Cell Function

H. Kiyonari, Takeshi Kimura, T. Kita, 2016, Diabetes.

Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes

R. Tian, R. Frausto, I. Sweet, 2023, Cell reports.

Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3

K. Iwaisako, E. Hatano, S. Uemoto, 2017, Cancer science.

Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion

Takeshi Kimura, S. Matsuda, E. Nishi, 2017, RMD Open.

Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model

R. Takahashi, Takeshi Kimura, T. Kita, 2014, Neurobiology of Aging.

Deficiency of Nardilysin in the Liver Reduces Serum Cholesterol Levels.

T. Kita, M. Ohno, E. Nishi, 2021, Biological & pharmaceutical bulletin.

PJ-344 Who is Suitable for Screening of Silent Coronary Atherosclerosis by 64 Slices-MDCT? : Retrospective Analysis in Asymptomatic 144 Patients(PJ058,CT/MRI (Coronary/Vascular) 1 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

R. Taniguchi, H. Fujiwara, T. Miyamoto, 2009 .

Nardilysin Is Required for Maintaining Pancreatic β-Cell Function

H. Kiyonari, Takeshi Kimura, T. Kita, 2016, Diabetes.

Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model

R. Takahashi, Takeshi Kimura, T. Kita, 2014, Neurobiology of Aging.

In Patients With Heart Failure, Cardiac Troponin T is a Reliable Predictor of Long-term Echocardiographic Changes and Adverse Cardiac Events

R. Taniguchi, Yukihito Sato, H. Fujiwara, 2009 .

Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.

H. Seno, Takeshi Kimura, T. Chiba, 2018, JCI insight.

Nardilysin determines hematopoietic stem cell fitness by regulating protein synthesis.

E. Nishi, A. Takaori-Kondo, Mikiko Ohno, 2023, Biochemical and biophysical research communications.

Nardilysin in vascular smooth muscle cells controls blood pressure via the regulation of calcium dynamics.

E. Nishi, Hirotaka Iwasaki, Mikiko Ohno, 2024, Biochemical and biophysical research communications.

Null mutation of exocyst complex component 3-like does not affect vascular development in mice

F. Sugiyama, H. Ogita, M. Ema, 2023, Experimental animals.

Genome-wide profiling of nardilysin target genes reveals its role in epigenetic regulation and cell cycle progression

Takeshi Kimura, T. Kita, E. Nishi, 2017, Scientific Reports.